Morro Bay Resources Ltd. Posts Filing Statement, Completes Transaction and Raises $3.3 Million
Calgary, Alberta (FSCwire) - Morro Bay Resources Ltd. (“Morro Bay” or the “Company”) (TSXV: MRB, OTCPink: MRRBF) is pleased to announce that in regard to the previously announced transaction with Experion Biotechnologies Inc. (“Experion”):
- Morro Bay has filed its Filing Statement dated September 25, 2017 on SEDAR (www.sedar.com);
- Morro Bay has changed its name to Viridium Pacific Group Ltd.;
- Morro Bay has consolidated its common shares on the basis of 3.603457 current Morro Bay common shares for one (1) post-consolidation Morro Bay common share resulting in Morro Bay having 3,386,538 common shares outstanding;
- Morro Bay has completed the transaction with Experion—a licensed producer of Cannabis;
- Subject to Final Exchange Acceptance, Morro Bay has raised gross proceeds of $3.3 million through the previously announced private placement offering;
- It is anticipated that, subject to compliance with certain requirements and requests from the TSX Venture Exchange, Viridium Pacific Group Ltd. (formerly Morro Bay) will receive TSX Venture Exchange Final Acceptance by on or before October 6, 2017 and the common shares will commence trading shortly thereafter; and
- The Viridium Pacific Group Ltd. (formerly Morro Bay) trading symbol on the TSX Venture Exchange will be VIR.
Filing Statement and Other Securities Filings
On September 28, 2017 Morro Bay filed on SEDAR a Filing Statement dated September 25, 2017 (the “Filing Statement”) in regard to its business combination with Experion as previously announced in Morro Bay’s press release dated August 10, 2017 (the “Transaction”). A summary of the Transaction and the Offering (as defined herein) is as follows but the within description is subject to full description contained in the Filing Statement.
Morro Bay’s SEDAR filings can now be found under the SEDAR Issuer Profile name “Viridium Pacific Group Ltd.”
Closing of Transaction
The Transaction has been completed as described in the Filing Statement, subject only to completion of the Offering.
Prior to the completion of the Transaction, Morro Bay has:
- Amended its Articles of Incorporation changing its name from Morro Bay Resources Ltd. to Viridium Pacific Group Ltd.
- Filed Articles of Continuance pursuant to the Canada Business Corporations Act; and
- Consolidated the Morro Bay common shares on the basis of 3.603457 current Morro Bay common shares for one (1) post-consolidation Morro Bay common share resulting in Morro Bay having 3,386,538 common shares outstanding.
In this News Release and given the name change, Morro Bay is hereinafter referred to as Viridium Pacific Group Ltd. or ”Viridium” and the outstanding common shares are hereinafter referred to as the “Viridium Common Shares”.
The completion of the Transaction represents a Reverse Take-over and Change of Business pursuant to TSX Venture Exchange Policies. Viridium is a Life Sciences Issuer in accordance with the TSX Venture Exchange Policies (the “Exchange Policies”).
Experion has 13,333,333 common shares outstanding. Pursuant to the terms of the Transaction, Viridium has acquired 10,833,333 Experion common shares in exchange for 33,935,758 Viridium Common Shares. Pursuant to an agreement reached with Northern Vine Canada Inc. (announced on September 12, 2017) Viridium has agreed to acquire the remaining Experion common shares in exchange for the shares in Northern Vine Canada Inc. owned by Experion (“Share Swap Agreement”). The closing of the Share Swap Agreement has been completed subject only to the closing documents being released from escrow within two (2) days after the Viridium Common Shares having traded for five (5) days on the TSX Venture Exchange. Upon closing of the Share Swap Agreement the Experion common shares acquired by Experion will be cancelled. Therefore, upon completion the Share Swap Agreement, Experion will become a wholly owned subsidiary of Viridium.
In addition, as part of the Transaction, Viridium has completed the acquisition of the Experion debentures in the total principal amount of $1,056,000 and accruing interest at 8% (the “Debentures”). As previously announced on August 10, 2017, Viridium and the holders of the Debentures have agreed to sell the Debentures to Viridium in exchange for 1,771,962 Viridium units (the “Debenture Units”). The purchase of the Debentures has been completed. The Debenture Units consist of one Viridium Common Share and one Viridium Common Share purchase warrant (the “Debenture Acquisition Warrants”) for each $0.60 owing pursuant to the Debentures. The Debenture Acquisition Warrants are exercisable to acquire one Viridium Common Share at a price of $0.80 and expire on June 27, 2018. Viridium is now the owner of all of the Debentures.
The Offering
As announced on June 7, June 8, 2017, and August 10, 2017 Viridium retained Wellington-Altus Private Wealth Inc. (the “Agent”) to act as agent in regard to an offering raising gross proceeds of a minimum of $500,000 and a maximum of $3,000,000 by way of a brokered private placement (the “Offering”). In addition, as part of the Offering, the Agent was granted an option to cover over-allotments and for market stabilization purposes (the “Over-Allotment Option”), which will allow the Agent to arrange for purchasers to acquire up to 10% of the number of Units sold under the Offering. The Agent has elected to exercise the Over-Allotment Option.
Subject only to Final Exchange Acceptance, the Offering is completed. Gross proceeds of $3,000,000 plus $300,000 pursuant to the Over-Allotment Option have been raised resulting in the issuance of 5,500,000 Viridium Units.
Each Viridium Unit consists of one Viridium Share and one-half of one Viridium Share purchase warrant (each whole common share purchase warrant hereinafter referred to as the “Offering Warrant”). Each Offering Warrant is exercisable to acquire one common share of Viridium at a price of $0.80 and expiring on June 27, 2018. Pursuant to the Offering 5,500,000 Viridium Common Shares have agreed to be issued and 2,750,000 Offering Warrants will be issued.
The fees and expenses payable to the Agent for the Offering is in the total amount of $236,402. In addition, the Agent is entitled to receive warrants to purchase 355,670 Offering Units (the “Agent’s Option”). The Agent’s Option will expire on June 27, 2018 and is exercisable at the price of $0.60 for each Agent’s Option.
Viridium Outstanding Shares
In summary, the total outstanding Viridium securities is as follows:
Viridium Outstanding Securities
Viridium Common Shares | Viridium Warrants | |
Former Morro Bay shares | 3,386,538 | |
Viridium Common Shares issued to the Experion shareholders | 33,935,758 | |
Viridium Units issued to the Debentureholders | 1,771,962 | 1,771,962 |
Subtotal | 39,094,258 | 1,771,962 |
Viridium Units to be issued pursuant to the Offering | 5,000,000 | 2,500,000 |
Viridium Units to be issued pursuant to Over-Allotment Option | 500,000 | 250,000 |
Total(1) | 44,594,258 | 4,512,962 |
Note: (1) Does not include 335,670 Agent’s Options (335,670 Viridium Common Shares and 167,835 Offering Warrants) and does not include any Viridium Common Shares which may be issued pursuant to its Stock Option Plan or restricted Share Unit Plan.
On a fully diluted basis (assuming the exercise of all of the Viridium Warrants and the Agent’s Option), Viridium will have 49,107,220 Viridium Common Shares outstanding.
In addition, pursuant to its Stock Option Plan and Restricted Share Unit Plan, Viridium has available for issuance up to 4,409,424 stock options or restricted share units (“Incentive Shares”). Viridium currently has outstanding only 24,975 options to purchase Viridium Common Shares (which were former options granted by Morro Bay). It is anticipated that grants of Incentive Shares will be announced after board of directors’ approval of same.
A portion of the Viridium Common Share consideration paid by Viridium for the Experion common shares will be held in escrow. 23,285,172 Viridium Common Shares will be subject to escrow pursuant the TSX Venture Exchange Policies which will be deposited with Computershare Trust Company of Canada. 2,117,591 of these escrowed shares will be subject to a Surplus Escrow (as defined by the Exchange Policies) and 21,167,581 escrowed shares will be subject to a Value Escrow (as defined by the Exchange Policies) including, as required by the TSX Venture Exchange, Seed Share Resale Restrictions (as defined by Exchange Policy 5.4). Pursuant to the applicable Exchange Policies, the Value Escrow Viridium Common Shares will be released from escrow 10% as of issuance of the Final Exchange Bulletin (the “Final Bulletin”) and the remaining Viridium Common Shares held in the Value Escrow will be released in six equal tranches of 15% every six months following the Final bulletin date. Pursuant to the Surplus Escrow Agreements 5% of the Surplus Escrow Viridium Common Shares will be released on the Final Bulletin date, 5%--6 months thereafter, 10%--12 months thereafter, 10%--18 months thereafter, 15%--24 months thereafter, 15%--30 months thereafter, and 40%--36 months thereafter. If Viridium meets the TSX Venture Exchange's Tier 1 minimum listing requirements, the release of the escrowed Common Shares may be accelerated. An accelerated escrow release will not commence until Viridium has made application to the TSX Venture Exchange for listing as a Tier 1 issuer and the TSX Venture Exchange has issued a bulletin that announces the acceptance for listing of Viridium on Tier 1 of the TSX Venture Exchange. The escrow conditions may also be reduced or removed in the event Viridium ceases to be an issuer listed on the TSX Venture Exchange.
Directors and Management
As a result of the Transaction a change of directors has occurred. As appointed at the Morro Bay shareholder meeting held on July 14, 2017, Michael Steele and Benjamin Eastwood have been appointed to the Viridium board of directors. Keith Erickson, Ken Younger, and Matt Zubot have resigned from the board of directors and Stephen Serenas (director and CEO of Experion), Robert Wilson (CFO of Experion), and Betty Dusange-Hayer have been appointed to the Viridium board of directors. As a result, the current Viridium board of directors is as follows:
Stephen Serenas Robert Wilson
John Zang Michael Steele
Benjamin Eastwood Betty Dusange-Hayer
In addition, John Zang has ceased to be the Chief Executive Officer of Morro Bay/Viridium and Denny Chow has ceased to be the Chief Financial Officer. In their place Stephen Serenas has been appointed as Chief Executive Officer and Robert Wilson has been appointed the Chief Financial Officer of Viridium. In addition, Jarrett Malnarick has been appointed the Chief Operating Officer of Viridium. John Zang has remained as the Corporate Secretary of Viridium. As a result the current officers of Viridium are as follows:
Stephen Serenas (CEO) Robert Wilson (CFO)
Jarrett Malnarick (COO) John Zang (Corporate Secretary)
Biographies and the shareholdings of the Viridium directors and officers can be found at pages 92 to 95 of the Filing Statement.
Experion
Experion is a science-led company conducting business in the cannabis production industry. Experion holds a license to produce cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (Canada) (the “ACMPR”).
Experion intends to be a low-cost producer and distributor of cannabis and cannabis products. Subject to the receipt of all necessary licenses and approvals Experion intends to operate in the following areas:
- production of whole plant “starter material”;
- production of dried marijuana flowers; and
- distribute its production from numbers (1) and (2) as permitted by the ACMPR or other relevant legislation including the wholesale distribution of its starter material to licensed growers and marijuana flower product for wholesale and retail distribution across Canada.
On August 18, 2017, pursuant to section 35 of the ACMPR, Health Canada granted to Experion a license to produce cannabis in Canada (the “License to Produce”). Pursuant to the License to Produce, Experion is hereafter permitted to grow cannabis in its current facilities located near Mission, BC. (the “Mission Site”). The Experion facility consists of an 8,300 square foot building which includes 2,000 square feet of indoor cannabis canopy growing space. Other areas in the structure include a lab/testing area, a secure vault for storage, a secure records-keeping area, and administrative and meeting rooms. In addition to this facility, Experion also plans on constructing 40,000 square feet of greenhouse canopy, and subject to Health Canada approval, expand its medical-grade cannabis production at the Mission Site. Experion has currently not applied for the necessary permits and licenses to commence construction, nor has it obtained Health Canada approval to utilize the planned greenhouse for cannabis production.
Other Matters
The Transaction and Offering remain subject to the final acceptance of the TSX Venture Exchange. Shortly after Final Approval the common shares will return to trading under the symbol VIR.
For further information regarding the Transaction, please refer to the Filing Statement available on SEDAR at www.sedar.com. Investors are cautioned that, except as disclosed in such Filing Statement any information released or received with respect to the Transaction and the Offering may not be accurate or complete and should not be relied upon. Trading in the securities of Viridium should be considered highly speculative.
Not a United States Offer: This press release does not constitute an offer of securities for sale in the United States or to “U.S. persons” (“U.S. persons”), as such term is defined in Regulation S promulgated under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”). The securities being offered have not been, nor will be, registered under the U.S. Securities Act or any state securities laws, and may not be offered or sold in the United States or to U.S. persons absent registration or an applicable exemption from such registration requirements.
Trading Halt: Morro Bay’s common shares are currently halted and Morro Bay anticipates they will remain halted for a period of time as required by the TSX Venture Exchange policies.
Disclosure
The TSX Venture Exchange has in no way passed upon the merits of the proposed Reverse Take-over Transaction and has neither approved nor disapproved the contents of this news release.
This press release contains forward-looking information within the meaning of Canadian securities laws. Such information includes, without limitation, information regarding the completion of the proposed acquisition and the Offering; and the anticipated business plan of the Company subsequent to completion of the transactions described herein. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.
For further information:
VIRIDIUM PACIFIC GROUP LTD.
John Zang
Corporate Secretary
Telephone: 403 680 9264
Email: jzanglaw@gmail.com
To view this press release as a PDF file, click onto the following link:public://news_release_pdf/viridiumpacific10022017.pdf
Source: Viridium Pacific Group Ltd. (TSX Venture:VIR)
To follow Viridium Pacific Group Ltd. on your favorite social media platform or financial websites, please click on the icons below.
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Copyright © 2017 Filing Services Canada Inc.